title: Infiximab for treatment of systemic amyloidosis associated with Crohn's disease.
authors: Yosra
authors: Y
authors: Said
authors: Radhouane
authors: R
authors: Debbeche
authors: Lamine
authors: L
authors: Hamzaoui
authors: Mondher
authors: M
authors: Lounissi
authors: Senda
authors: S
authors: Trabelsi
authors: Slim
authors: S
authors: Bouzaidi
authors: Mohammed
authors: M
authors: Salem
authors: L
authors: L
authors: Abdelmoula
authors: Taoufik
authors: T
authors: Najjar
mesh_terms: D000328:Adult; D000686:Amyloidosis / Q000150:complications / Q000188:drug therapy*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D007674:Kidney Diseases / Q000150:complications; D008297:Male
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab